Clinical Trials Logo

Clinical Trial Summary

In the ECMOsorb study the impact of a veno-arterial -ECMO in combination with an extracorporeal cytokine hemadsorption system in critically ill patients with cardiogenic shock is to be examined

Clinical Trial Description

The prospective, interventional, randomised controlled and blinded ECMOsorb study investigates in critically ill patinets with cardiogenic shock and with veno-arterial ECMO (VA-ECMO) treatment the impact of an extracorporeal cytokin hemadsorption system on hemodynamics, defined by the Inotropic Score 72 hours after initiation of the adsorber (intervention) or normal ECMO tube (control) in the VA-ECMO. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05027529
Study type Interventional
Source Jena University Hospital
Contact Christian Schulze, Prof.
Phone 004936419324100
Email [email protected]
Status Recruiting
Phase N/A
Start date May 21, 2021
Completion date June 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03283995 - Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology
Recruiting NCT04325035 - The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock Phase 2
Recruiting NCT02301819 - ExtraCorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock N/A
Completed NCT01367743 - Study Comparing the Efficacy and Tolerability of Epinephrine and Norepinephrine in Cardiogenic Shock Phase 4
Recruiting NCT03313687 - SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Not yet recruiting NCT04234659 - PPCM Observational Study (Peripartum Cardiomyopathy)
Completed NCT04144660 - "Treatment Use of ECMO In Pregnancy or Peripartum Patient."
Recruiting NCT04548739 - Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
Recruiting NCT04141410 - Global Longitudinal Strain Assessment in Cardiogenic Shock During Sepsis
Completed NCT02591771 - Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock Phase 2
Terminated NCT02279979 - Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial N/A
Completed NCT01374867 - CardShock Study and Registry N/A
Recruiting NCT00093301 - Levosimendan Versus Dobutamine in Shock Patients Phase 2/Phase 3
Recruiting NCT03729765 - Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients N/A
Recruiting NCT03813134 - Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock N/A
Completed NCT02754193 - Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO) N/A
Not yet recruiting NCT04990349 - Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock Phase 3
Terminated NCT04084015 - Early Insertion of Axillary Impella® With VA ECMO N/A
Recruiting NCT03141255 - Cardiogenic Shock Intravascular Cooling Trial N/A
Recruiting NCT03532529 - Evaluation of Speckle Tracking Parameters as Predictors of Successful VA SPECKLE ECMO